MA54228A - Procédés de préparation de dérivés de benzodiazépine cytotoxiques - Google Patents

Procédés de préparation de dérivés de benzodiazépine cytotoxiques

Info

Publication number
MA54228A
MA54228A MA054228A MA54228A MA54228A MA 54228 A MA54228 A MA 54228A MA 054228 A MA054228 A MA 054228A MA 54228 A MA54228 A MA 54228A MA 54228 A MA54228 A MA 54228A
Authority
MA
Morocco
Prior art keywords
methods
benzodiazepine derivatives
cytotoxic benzodiazepine
preparing cytotoxic
preparing
Prior art date
Application number
MA054228A
Other languages
English (en)
Inventor
Michael Reardon
Richard A Silva
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of MA54228A publication Critical patent/MA54228A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/22Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/20Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA054228A 2018-11-12 2019-11-11 Procédés de préparation de dérivés de benzodiazépine cytotoxiques MA54228A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862758814P 2018-11-12 2018-11-12

Publications (1)

Publication Number Publication Date
MA54228A true MA54228A (fr) 2021-09-22

Family

ID=68835289

Family Applications (1)

Application Number Title Priority Date Filing Date
MA054228A MA54228A (fr) 2018-11-12 2019-11-11 Procédés de préparation de dérivés de benzodiazépine cytotoxiques

Country Status (12)

Country Link
US (3) US10851117B2 (fr)
EP (2) EP4361128A3 (fr)
JP (2) JP7437395B2 (fr)
KR (1) KR20210098470A (fr)
CN (2) CN112996792B (fr)
AU (1) AU2019379104A1 (fr)
CA (1) CA3119358A1 (fr)
IL (1) IL283045A (fr)
MA (1) MA54228A (fr)
SG (1) SG11202104360YA (fr)
TW (1) TW202033530A (fr)
WO (1) WO2020102051A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI840039B (zh) * 2017-04-20 2024-04-21 美商伊繆諾金公司 製備吲哚啉苯并二氮平衍生物之方法
MA54228A (fr) 2018-11-12 2021-09-22 Immunogen Inc Procédés de préparation de dérivés de benzodiazépine cytotoxiques
AU2023298568A1 (en) 2022-06-30 2025-01-09 Toray Industries, Inc. Pharmaceutical composition for cancer treatment and/or prevention

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902707A (en) * 1985-04-30 1990-02-20 Eli Lilly And Company Bicyclic pyrazolidinones, compositions and use
US5015738A (en) * 1989-08-07 1991-05-14 Hoechst-Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
CN102050824A (zh) * 2009-11-04 2011-05-11 上海阳帆医药科技有限公司 哌嗪并三唑衍生物
UA120696C2 (uk) 2011-02-15 2020-01-27 Імуноген, Інк. Спосіб одержання кон'югатів
RU2539658C1 (ru) 2013-12-10 2015-01-20 Федеральное государственное казенное учреждение "33 Центральный научно-исследовательский испытательный институт Министерства обороны Российской Федерации" Способ получения бензилхлорида
JP6843080B2 (ja) 2015-06-29 2021-03-17 イミュノジェン・インコーポレーテッド システイン改変抗体の複合体
SG10202005144TA (en) 2015-06-29 2020-07-29 Immunogen Inc Anti-cd123 antibodies and conjugates and derivatives thereof
JP2018522018A (ja) * 2015-07-21 2018-08-09 イミュノジェン・インコーポレーテッド 細胞毒性ベンゾジアゼピン誘導体の調製方法
FI3380525T3 (fi) 2015-11-25 2024-01-30 Immunogen Inc Lääkeformulaatioita ja niiden käyttömenetelmiä
ES2935346T3 (es) 2017-01-25 2023-03-06 Immunogen Inc Métodos para preparar derivados de benzodiazepina citotóxicos
WO2019133652A1 (fr) 2017-12-28 2019-07-04 Immunogen, Inc. Dérivés de benzodiazépine
MA54228A (fr) 2018-11-12 2021-09-22 Immunogen Inc Procédés de préparation de dérivés de benzodiazépine cytotoxiques

Also Published As

Publication number Publication date
US20230045079A1 (en) 2023-02-09
WO2020102051A1 (fr) 2020-05-22
CN118324848A (zh) 2024-07-12
CN112996792A (zh) 2021-06-18
JP2024056819A (ja) 2024-04-23
EP3880681B1 (fr) 2024-03-13
US11396519B2 (en) 2022-07-26
EP4361128A3 (fr) 2024-07-17
KR20210098470A (ko) 2021-08-10
US20210122768A1 (en) 2021-04-29
US20200172555A1 (en) 2020-06-04
JP2022512935A (ja) 2022-02-07
JP7437395B2 (ja) 2024-02-22
US11981688B2 (en) 2024-05-14
AU2019379104A1 (en) 2021-06-03
SG11202104360YA (en) 2021-05-28
TW202033530A (zh) 2020-09-16
IL283045A (en) 2021-06-30
CA3119358A1 (fr) 2020-05-22
WO2020102051A8 (fr) 2020-06-18
CN112996792B (zh) 2024-04-26
EP3880681A1 (fr) 2021-09-22
EP4361128A2 (fr) 2024-05-01
US10851117B2 (en) 2020-12-01

Similar Documents

Publication Publication Date Title
EP3980073A4 (fr) Procédés de préparation de complexes protéine-oligonucléotide
MA49752A (fr) Procédés de préparation de composés de pyrrolidine
EP3826682A4 (fr) Supports dérivés de cholix pour administration orale de chargement hétérologue
EP3331896A4 (fr) Procédés de préparation d'acides biliaires et de leurs dérivés
MA54253A (fr) Procédé de préparation de dérivés de 2-chloro-4-hétéroaryl-pyridimidines
MA54254A (fr) Dérivés de benzodiazépine cytotoxique
EP3833343A4 (fr) Dérivés hétérocycliques de flavone, compositions et procédés associés
EP3481827A4 (fr) Dérivés d'imidazo[1,2-a]pyridine, leurs procédés de préparation et leur utilisation
EP3969457A4 (fr) Procédés de préparation d'indoles macrocycliques
CY1122553T1 (el) Μεθοδοι παρασκευης κυτταροτοξικων παραγωγων βενζοδιαζεπινης
MA49700A (fr) Procédé amélioré pour la préparation de dérivés d'aminopyrimidine
EP3980013A4 (fr) Procédés de préparation de composés aminopyrimidine
EP3863612A4 (fr) Procédés de préparation de cyclooctènes fonctionnalisés
MA54225A (fr) Procédés de préparation de dérivés de benzodiazépine cytotoxiques
MA54228A (fr) Procédés de préparation de dérivés de benzodiazépine cytotoxiques
EP3597674A4 (fr) Procédé de préparation de copolymère
MA54396A (fr) Procédé de préparation de n-phénylpyrazole-1-carboxamides
DK3573948T3 (da) Fremgangsmåder til fremstilling af cytotoksiske benzodiazepinderivater
EP3390368A4 (fr) Procédés de préparation de 5,6-dihydro-6-phénylbenzo[f]isoquinoléine-2-amine substituée
MA56504A (fr) Dérivés de pyridin-3-yle
MA51510A (fr) Procédés de préparation de dérivés d'indolinobenzodiazépine
EP3505525A4 (fr) Procédé de préparation de rubusoside
EP3733651A4 (fr) Procédé de préparation de calcobutrol
EP3436439A4 (fr) Procédé de préparation de dérivés de diphénylpyrazine
EP3408252A4 (fr) Procédé de préparation de dérivés de prostacycline